The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice

MLA

Sung Hee Choi, et al. “The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice.” International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 4906, Apr. 2022. EBSCOhost, https://doi.org/10.3390/ijms23094906.

APA

Sung Hee Choi, Jee-In Lee, Yun-Kyung Lee, Hak Chul Jang, Eu Jeong Ku, Bo-Rahm Kim, & Tae Jung Oh. (2022). The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice. International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 4906. https://doi.org/10.3390/ijms23094906

Chicago

Sung Hee Choi, Jee-In Lee, Yun-Kyung Lee, Hak Chul Jang, Eu Jeong Ku, Bo-Rahm Kim, and Tae Jung Oh. 2022. “The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice.” International Journal of Molecular Sciences; Volume 23; Issue 9; Pages: 4906, April. doi:10.3390/ijms23094906.